Diamond Hill Capital Management LLC Investment Advisor Buys Shares of 52,316 HCA Healthcare, Inc. $HCA

Key Points

• Diamond Hill Capital Management initiated a stake of 52,316 HCA Healthcare shares during the second quarter, valued at approximately $20.4 million. Institutional investors collectively own 62.73% of HCA’s outstanding stock.
• HCA Healthcare exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, with revenue up 8.7% year over year.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $465.59, while HCA declared a quarterly dividend of $0.78 per share, equivalent to a 0.8% annual yield.

Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 52,316 shares of the company's stock, valued at approximately $20,397,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Brighton Jones LLC purchased a new stake in HCA Healthcare in the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC raised its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock worth $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC grew its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after buying an additional 33 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. grew its holdings in shares of HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company's stock worth $52,328,000 after purchasing an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Stephens dropped their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. JPMorgan Chase & Co. lowered their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 19th. Cantor Fitzgerald reduced their target price on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 7th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Finally, Robert W. Baird decreased their price objective on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $465.59.

HCA Healthcare Stock Down 0.0%

Shares of NYSE:HCA opened at $404.61 on Monday. The company's fifty day moving average is $393.41 and its 200 day moving average is $446.61. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The stock has a market cap of $87.60 billion, a PE ratio of 13.55, a PEG ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $6.84 earnings per share. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source